Model policy for law-enforcement officer investigating overdose; notification to prescriber.
Summary
HB2435 amends Virginia Code § 9.1-102, which sets out the powers and duties of the Department of Criminal Justice Services and the Criminal Justice Services Board. The bill adds a new requirement that the Board establish a model policy for law-enforcement officers responding to or investigating an overdose when prescriber information is obtained during the investigation. Under that model policy, officers would notify the prescriber that a controlled substance prescribed by that prescriber was involved in the overdose, if the prescription information is known.
The bill also specifies that prescriber notification is not required if doing so would jeopardize an active law-enforcement investigation. In practical terms, the measure directs the state’s criminal justice policy-making body to create guidance for police agencies on overdose investigations and communication with medical prescribers, while preserving investigative discretion in sensitive cases. The amendment is added to a broad statute that already authorizes the Board to set training standards, model policies, certification rules, and other statewide criminal justice guidance.
Impact
HB2435 changes state law by expanding the Department of Criminal Justice Services’ statutory duties to include developing a model overdose-investigation notification policy. It affects law-enforcement agencies and officers conducting overdose responses or investigations, and it may also affect prescribers of controlled substances who could receive notifications when a patient’s prescribed medication is implicated in an overdose. The bill does not create a direct mandate for prescribers themselves, but it establishes statewide policy guidance for when and how law enforcement should notify them.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislative process. It advanced through subcommittee, committee, and floor votes with strong margins, including unanimous committee votes and overwhelming passage in both chambers. The absence of recorded opposition in the later stages suggests general agreement with the goal of improving overdose response and communication with prescribers.
Contention
The only notable point of contention reflected in the record is the initial subcommittee vote, which was 5-1 in favor of reporting the bill with a substitute, indicating at least some concern about the exact wording or scope of the policy. The substitute likely addressed implementation details, especially the balance between notifying prescribers and protecting active investigations. No committee transcripts are available, so the specific objections are not documented, but the final votes suggest those concerns were resolved.